Open original FDA record ↗Recall record
- FDA identifier
- Z-2861-2026
- Company in FDA record
- Nuclein LLC
- FDA classification date
- Aug 3, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to a software issue which may result in false co-infection (e.g., Positive for Flu A, when SARS-CoV-2 is present).
Source facts
- Action
- On 06/25/2025, a "MEDICAL DEVICE RECALL" Letter was emailed to customers informing them that, Nuclein identified an incorrect software file on a small number of DASH instruments that creates a possibility for the affected instruments to make incorrect calls that indicate coinfection in the patient tested. On 07/16/2026, the firm emailed an updated "URGENT: MEDICAL DEVICE RECALL" Letter. -Customer were informed regarding updates to the reason for the recall and potential health risks. -Customer were instructed to: All affected DASH Instrument identified in Section 6 (below) have already been replaced. Please complete the Acknowledgement and Receipt Form below and either email the completed form to customersupport@nuclein.com or mail to the address provided at the bottom of the Acknowledgement and Receipt Form. For Questions - contact Nuclein at Phone: (888) 992-DASH on Monday through Friday, 8:30 AM to 5:30 PM, CST. Email: customersupport@nuclein.com Website: https://www.Nuclein.com/contact-us/
- Initiated
- 2025-06-25
- Root cause
- Process control
- Distribution
- US Nationwide distribution in the state of Texas.
- Recall number
- Z-2861-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221406
- FDA classified
- 2026-08-03
- Recall event number
- 99360